Johnson Controls
JCI
155.93
-2.83
-1.78%
Johnson Controls
US · JCI
#250 by market cap
Listed 1970
155.93
-2.83
-1.78%
Live - 5344 symbols - heartbeat 160s ago
· 2026-10-08 07:07
Pre-market
154.23
-1.09%
After-hours
155.93
0.00%
- Market cap
- 94.45B
- P/E (TTM)i
- 27.40
- P/Bi
- 7.01
- EPSi
- 5.03
- Div yieldi
- 1.03%
- 52W posi
- 92%
Reader sentiment
Are you bullish or bearish on JCI?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 3.11, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +2.81% YoY
Margins
- Gross margin
- 36.41%
- Operating margin
- 11.99%
- Net margin
- 13.95%
Key ratios & quality
- Enterprise valuei
- 103.95B
- PEG ratioi
- 0.94
- Altman Z-Scorei
- 3.11
PEG uses trailing P/E against the 3-year net income growth rate (29.03%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 23.40B | 23.97B | 22.32B | 23.67B | 20.64B | 22.33B | 22.95B | 23.60B |
| Gross profit | 7.67B | 7.69B | 7.41B | 8.06B | 7.09B | 7.80B | 8.08B | 8.59B |
| Selling & admin expenses | 5.64B | 6.24B | 5.67B | 5.26B | 5.08B | 5.39B | 5.66B | 5.76B |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 2.03B | 1.45B | 1.75B | 2.80B | 2.01B | 2.42B | 2.42B | 2.83B |
| Pretax profit | 1.55B | 1.06B | 903.00M | 2.61B | 1.11B | 1.11B | 1.52B | 1.97B |
| Tax | 197.00M | -233.00M | 108.00M | 868.00M | -182.00M | -468.00M | 111.00M | 245.00M |
| Net profit | 2.38B | 5.89B | 795.00M | 1.87B | 1.72B | 2.03B | 1.90B | 3.51B |
| Basic EPS | 2 | 7 | 1 | 2 | 2 | 3 | 3 | 5 |
| Diluted EPS | 2.32 | 6.49 | 0.84 | 2.27 | 2.19 | 2.69 | 2.52 | 5.03 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 5.68B | 6.05B | 6.44B | 5.80B | 6.14B | 6.61B |
| Gross profit | 2.07B | 2.25B | 2.35B | 2.07B | 2.26B | 2.47B |
| Selling & admin expenses | 1.43B | 1.42B | 1.52B | 1.22B | 1.40B | 1.41B |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 642.00M | 829.00M | 830.00M | 853.00M | 861.00M | 1.07B |
| Pretax profit | 501.00M | 705.00M | 355.00M | 708.00M | 738.00M | 917.00M |
| Tax | 26.00M | 87.00M | 85.00M | 152.00M | 126.00M | 165.00M |
| Net profit | 526.00M | 778.00M | 1.76B | 525.00M | 616.00M | 752.00M |
| Basic EPS | 1 | 1 | 3 | 1 | 1 | 1 |
| Diluted EPS | 0.72 | 1.07 | 2.67 | 0.85 | 1.00 | 1.23 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 11.82B | 12.39B | 10.05B | 10.00B | 11.69B | 10.74B | 11.18B | 10.16B |
| Cash & ST investments | 185.00M | 2.81B | 1.95B | 1.34B | 2.03B | 828.00M | 606.00M | 379.00M |
| Inventory | 1.82B | 1.81B | 1.77B | 2.06B | 2.67B | 1.87B | 1.77B | 1.82B |
| Total assets | 48.80B | 42.29B | 40.82B | 41.89B | 42.16B | 42.24B | 42.70B | 37.94B |
| Total current liabilities | 11.25B | 9.07B | 8.25B | 9.10B | 11.24B | 11.08B | 11.96B | 10.94B |
| Short-term debt | 1.31B | 511.00M | 293.00M | 234.00M | 1.53B | 1.01B | 1.49B | 1.29B |
| Long-term debt | 9.62B | 6.71B | 7.53B | 7.51B | 7.43B | 7.82B | 8.00B | 8.59B |
| Total liabilities | 26,339,000,000.00 | 21,458,000,000.00 | 22,282,000,000.00 | 23,137,000,000.00 | 24,756,000,000.00 | 24,548,000,000.00 | 25,334,000,000.00 | 24,985,000,000.00 |
| Total equity | 22.46B | 20.83B | 18.53B | 18.75B | 17.40B | 17.69B | 17.36B | 12.95B |
| Retained earnings | 6.60B | 4.83B | 2.47B | 2.03B | 1.15B | 1.38B | 848.00M | 0 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 11.35B | 11.85B | 10.16B | 10.44B | 10.99B | 11.28B |
| Cash & ST investments | 795.00M | 731.00M | 379.00M | 552.00M | 698.00M | 641.00M |
| Inventory | 1.76B | 1.83B | 1.82B | 1.93B | 1.93B | 1.96B |
| Total assets | 42.37B | 43.39B | 37.94B | 37.98B | 38.35B | 38.76B |
| Total current liabilities | 11.82B | 12.35B | 10.94B | 10.50B | 10.61B | 11.28B |
| Short-term debt | 1.82B | 1.85B | 1.29B | 1.00B | 910.00M | 1.18B |
| Long-term debt | 8.17B | 8.45B | 8.59B | 8.70B | 8.61B | 8.30B |
| Total liabilities | 25,335,000,000.00 | 26,348,000,000.00 | 24,985,000,000.00 | 24,750,000,000.00 | 24,811,000,000.00 | 25,244,000,000.00 |
| Total equity | 17.03B | 17.05B | 12.95B | 13.23B | 13.54B | 13.52B |
| Retained earnings | 599.00M | 746.00M | 0 | 278.00M | 0 | 0 |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 2.52B | 1.20B | 2.22B | 2.49B | 1.99B | 2.22B | 2.10B | 1.40B |
| Depreciation & amortization | 824.00M | 825.00M | 822.00M | 845.00M | 717.00M | 745.00M | 816.00M | 865.00M |
| Free cash flow | 1.87B | 616.00M | 1.78B | 1.94B | 1.50B | 1.78B | 1.60B | 965.00M |
| Dividends paid | -954.00M | -920.00M | -790.00M | -762.00M | -916.00M | -980.00M | -1.00B | -976.00M |
| Stock buybacks / issuance | -300.00M | -5.98B | -2.20B | -1.31B | -1.44B | -625.00M | -1.25B | -5.99B |
| Ending cash balance | 185.00M | 2.81B | 1.95B | 1.34B | 2.03B | 828.00M | 606.00M | 379.00M |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 599.00M | 995.00M | -442.00M | 544.00M | 641.00M | 1.29B |
| Depreciation & amortization | 202.00M | 190.00M | 280.00M | 164.00M | 169.00M | 162.00M |
| Free cash flow | 505.00M | 901.00M | -572.00M | 464.00M | 573.00M | 1.19B |
| Dividends paid | -245.00M | -243.00M | -243.00M | -245.00M | -244.00M | -245.00M |
| Stock buybacks / issuance | -330.00M | -310.00M | -5.02B | 0 | -215.00M | -635.00M |
| Ending cash balance | 795.00M | 731.00M | 379.00M | 552.00M | 698.00M | 641.00M |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 10.39 | 27.73 | 3.39 | 9.35 | 9.06 | 11.27 | 10.45 | 22.68 |
| ROA %i | 4.29 | 12.46 | 1.52 | 3.96 | 3.65 | 4.38 | 4.01 | 8.16 |
| ROIC %i | 7.55 | 19.86 | 3.15 | 7.03 | 6.71 | 8.15 | 8.02 | 14.36 |
| 5-year avg ROE %i | 7.46 | 10.95 | 8.74 | 11.62 | 11.98 | 12.16 | 8.70 | 12.56 |
| EBIT margin %i | 10.63 | 5.80 | 5.12 | 11.97 | 7.65 | 7.53 | 8.29 | 9.31 |
| FCF / sales %i | 4.72 | 2.57 | 7.96 | 8.18 | 5.51 | 6.28 | 6.99 | 4.09 |
| Current ratioi | 1.05 | 1.37 | 1.22 | 1.10 | 1.04 | 0.97 | 0.94 | 0.93 |
| Quick ratioi | 0.52 | 0.95 | 0.88 | 0.76 | 0.69 | 0.57 | 0.56 | 0.61 |
| Debt / assetsi | 22.40 | 17.07 | 19.16 | 18.48 | 21.25 | 20.89 | 22.23 | 26.04 |
| LT debt / equityi | 45.47 | 33.94 | 43.14 | 42.74 | 45.65 | 47.25 | 49.72 | 66.46 |
| Interest coveragei | 7.64 | 4.15 | 4.76 | 12.94 | 8.60 | 6.57 | 4.99 | 9.67 |
| Revenue CAGR (3Y) %i | 11.02 | 4.78 | -0.76 | 0.38 | -4.87 | 0.02 | -1.02 | 4.57 |
| Net income CAGR (3Y) %i | 11.42 | -- | -26.83 | -8.86 | -35.37 | 43.10 | 1.37 | 29.03 |
| FCF CAGR (3Y) %i | 59.05 | -2.22 | -- | 1.13 | 34.63 | -0.02 | -6.06 | -13.73 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 15.92 | 14.03 | 22.68 | 23.34 | 24.08 | 24.42 |
| ROA %i | 5.84 | 5.15 | 8.16 | 8.48 | 8.75 | 8.71 |
| ROIC %i | 10.63 | 9.47 | 14.36 | 14.56 | 15.10 | 15.21 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 12.49 | 10.92 | 9.31 | 10.31 | 11.10 | 11.71 |
| FCF / sales %i | 12.47 | 12.26 | 4.09 | 5.42 | 5.59 | 6.64 |
| Current ratioi | 0.96 | 0.96 | 0.93 | 0.99 | 1.04 | 1.00 |
| Quick ratioi | 0.56 | 0.56 | 0.61 | 0.64 | 0.69 | 0.67 |
| Debt / assetsi | 23.57 | 23.72 | 26.04 | 25.55 | 24.83 | 24.45 |
| LT debt / equityi | 51.67 | 53.35 | 66.46 | 65.90 | 63.72 | 61.56 |
| Interest coveragei | 9.02 | 8.72 | 9.67 | 12.23 | 13.17 | 14.00 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Products & Systems is the largest reported line at 69.49% of revenue, across 2 reported segments.
- Services follows at 30.51%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Products & Systems69.49%
Services30.51%
Quote time 2026-10-08 07:07:45 · For reference only, not investment advice and not tailored to your situation.